Necitumumab plus Gemcitabine and Cisplatin as First-Line Therapy in Patients with Stage IV EGFR-Expressing Squamous Non-Small-Cell Lung Cancer German Subgroup Data from an Open-Label, Randomized Controlled Phase 3 Study (SQUIRE) Article

Industry Collaboration International Collaboration

cited authors

  • Reck, Martin; Thomas, Michael; Kropf-Sanchen, Cornelia; Mezger, Joerg; Socinski, Mark A.; Depenbrock, Henrik; Soldatenkova, Victoria; Brown, Jacqueline; Krause, Thomas; Thatcher, Nick

authors

Publication Date

  • September 1, 2016

webpage

published in

category

keywords

  • EGFR-expressing tumors
  • German subgroup data
  • Necitumumab
  • SQUIRE
  • Squamous NSCLC

start page

  • 539

end page

  • 547

volume

  • 39

issue

  • 9